OKYO Pharma Ltd
NASDAQ:OKYO
Income Statement
Earnings Waterfall
OKYO Pharma Ltd
Income Statement
OKYO Pharma Ltd
| Mar-2020 | Mar-2021 | Mar-2022 | ||
|---|---|---|---|---|
| Revenue | ||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||
| Operating Expenses |
(1)
|
(3)
|
(5)
|
|
| Research & Development |
(0)
|
(0)
|
(1)
|
|
| Other Operating Expenses |
(1)
|
(2)
|
(4)
|
|
| Operating Income |
(1)
N/A
|
(3)
-113%
|
(5)
-77%
|
|
| Pre-Tax Income | ||||
| Interest Income Expense |
0
|
(0)
|
0
|
|
| Non-Reccuring Items |
(0)
|
(0)
|
0
|
|
| Pre-Tax Income |
(1)
N/A
|
(3)
-103%
|
(5)
-76%
|
|
| Net Income | ||||
| Tax Provision |
0
|
0
|
1
|
|
| Income from Continuing Operations |
(1)
|
(3)
|
(4)
|
|
| Net Income (Common) |
(1)
N/A
|
(3)
-111%
|
(4)
-55%
|
|
| EPS (Diluted) |
-8.62
N/A
|
-16.11
-87%
|
-17.17
-7%
|
|